These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Late and sustained intraocular pressure elevation related to intravitreal anti-VEGF injections: Cases requiring filtering surgery (French translation of the article)]. Leleu I; Penaud B; Blumen-Ohana E; Rodallec T; Adam R; Laplace O; Akesbi J; Nordmann JP J Fr Ophtalmol; 2018 Nov; 41(9):789-801. PubMed ID: 30348599 [TBL] [Abstract][Full Text] [Related]
3. EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Sisk RA; Rusia D; Zamora BG; Kuley A; Toussaint BW Retina; 2019 Oct; 39(10):1959-1964. PubMed ID: 30234855 [TBL] [Abstract][Full Text] [Related]
4. Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting. Vo Kim S; Fajnkuchen F; Sarda V; Qu-Knafo L; Bodaghi B; Giocanti-Aurégan A Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2165-2171. PubMed ID: 28831613 [TBL] [Abstract][Full Text] [Related]
5. Glaucoma filtration surgery following sustained elevation of intraocular pressure secondary to intravitreal anti-VEGF injections. Skalicky SE; Ho I; Agar A; Bank A Ophthalmic Surg Lasers Imaging; 2012 Jul; 43(4):328-34. PubMed ID: 22788585 [TBL] [Abstract][Full Text] [Related]
6. Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection. Lam J; Luttrell I; Ding L; Rezaei K; Chao JR; Chee Y; Olmos De Koo LC; Wen JC Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2489-2494. PubMed ID: 31388743 [TBL] [Abstract][Full Text] [Related]
7. SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence? Dedania VS; Bakri SJ Retina; 2015 May; 35(5):841-58. PubMed ID: 25905784 [TBL] [Abstract][Full Text] [Related]
17. A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab. Wehrli SJ; Tawse K; Levin MH; Zaidi A; Pistilli M; Brucker AJ Retina; 2012 Jul; 32(7):1295-301. PubMed ID: 22466465 [TBL] [Abstract][Full Text] [Related]
18. Ocular hypertension following intravitreal anti-vascular endothelial growth factor agents. Singh RS; Kim JE Drugs Aging; 2012 Dec; 29(12):949-56. PubMed ID: 23179897 [TBL] [Abstract][Full Text] [Related]